Drug Shortage Report for ALTACE HCT

Last updated on 2018-05-16 History
Report ID 19736
Drug Identification Number 02283131
Brand name ALTACE HCT
Common or Proper name ALTACE HCT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE RAMIPRIL
Strength(s) 12.5MG 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size na
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-11-30
Estimated end date
Actual end date 2018-05-15
Shortage status Resolved
Updated date 2018-05-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-08-17 English Compare
v2 2017-08-17 French Compare
v3 2018-01-23 English Compare
v4 2018-01-23 English Compare
v5 2018-01-23 French Compare
v6 2018-04-18 English Compare
v7 2018-04-18 French Compare
v8 2018-04-26 English Compare
v9 2018-04-26 French Compare
v10 2018-05-04 English Compare
v11 2018-05-04 French Compare
v12 2018-05-11 English Compare
v13 2018-05-11 French Compare
v14 2018-05-16 English Compare
v15 2018-05-16 French Compare

Showing 1 to 15 of 15